Soligenix prices $7.5 million public offering at $1.35 per share
PositiveFinancial Markets

Soligenix has successfully priced its public offering at $1.35 per share, raising $7.5 million. This funding is crucial for the company's ongoing projects and research initiatives, signaling confidence in its future growth and potential breakthroughs in the biotech sector.
— Curated by the World Pulse Now AI Editorial System